Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

6.7K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.7K
Blinding01:11

Blinding

2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Group Design02:01

Group Design

8.9K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
8.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Hazard Ratio01:12

Hazard Ratio

91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.

Journal of the American Heart Association·2026
Same author

Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.

Lancet (London, England)·2026
Same author

Validation and simplification of the MR PREDICTS @24H model for outcome prediction after endovascular thrombectomy for acute ischemic stroke.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and update.

European stroke journal·2026
Same author

Estimation of Acute Infarct Core and Hypoperfused Region from Baseline Noncontrast Computed Tomography and Computed Tomography Angiography Scans of Patients with Ischemic Stroke.

Stroke (Hoboken, N.J.)·2026
Same author

Late Window Imaging Selection for Endovascular Therapy of Large Vessel Occlusion Stroke: An International Survey.

Stroke (Hoboken, N.J.)·2026

Related Experiment Video

Updated: Jun 7, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

Real-time adaptive randomization of clinical trials.

Gui Liberali1, Eric Boersma2, Hester Lingsma3

  • 1Erasmus University, Rotterdam School of Management, Rotterdam, The Netherlands; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Journal of Clinical Epidemiology
|November 18, 2024
PubMed
Summary

Real-time adaptive randomization (RTAR) improves patient outcomes in clinical trials by allocating more participants to superior treatments, reducing mortality. This method effectively identifies the best treatment while maintaining statistical validity.

Keywords:
Adaptive clinical trialsForward-looking trialsMulti-armed banditsPatient beneficenceResponse-adaptive randomizationTemporal changes

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

Related Experiment Videos

Last Updated: Jun 7, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Cardiovascular Research

Background:

  • Randomized controlled trials (RCTs) are standard but can assign participants to inferior treatments.
  • Delayed endpoints in RCTs pose challenges for real-time treatment adaptation.
  • Balancing treatment allocation with learning about treatment efficacy is crucial.

Purpose of the Study:

  • To evaluate real-time adaptive randomization (RTAR) for clinical trials with delayed endpoints.
  • To assess the trade-offs of RTAR regarding mortality, confidence intervals (CIs), and statistical power.
  • To compare RTAR with traditional RCTs and block-based adaptive designs.

Main Methods:

  • Simulations using data from two large cardiovascular RCTs (GUSTO-1 and EUROPA).
  • Resampling treatment assignments and endpoints to mimic real-time and block-based adaptive randomization.
  • Evaluating RTAR's performance in optimizing treatment allocation and endpoint estimation.

Main Results:

  • RTAR quickly identifies superior treatments, allocating more patients to them and reducing overall mortality.
  • Endpoint rates and odds ratios remained within RCT confidence intervals, with tighter CIs for the superior arm.
  • RTAR demonstrated improved adaptation to changing endpoint rates within trials.

Conclusions:

  • RTAR enhances patient outcomes and narrows confidence intervals for superior treatments.
  • Benefits of RTAR are balanced by wider CIs for inferior arms and odds ratios.
  • Forward-looking adaptive variants offer intermediate benefits, and RTAR did not misidentify inferior arms as superior.